Global Cell and Gene Therapy CDMO Market Growth (Status and Outlook) 2026-2032
The global Cell and Gene Therapy CDMO market size is predicted to grow from US$ 3972 million in 2025 to US$ 6432 million in 2032; it is expected to grow at a CAGR of 7.1% from 2026 to 2032.
Cell and Gene Therapy CDMOs are organizations that provide professional, customized R&D and manufacturing outsourcing services for the research and commercialization of cell and gene therapy drugs. These services cover the entire chain of process development and manufacturing, from plasmids and viral vectors to cell drugs. Their core value lies in helping innovative cell and gene therapy (CGT) companies overcome industrialization bottlenecks caused by complex processes, high production costs, and stringent regulatory oversight, accelerating the drug development process from preclinical research to IND application and commercialization. Services include process development, analytical method development, GMP-level manufacturing, stability studies, and application document preparation, making them an indispensable key support force in modern CGT drug development.
The global Cell and Gene Therapy CDMO market is experiencing rapid growth driven by the surge in CGT drugs, pipeline advancements, and industrialization demands. North America and Europe, as mature markets, leverage their leading viral vector technologies, robust regulatory frameworks, and extensive CGT R&D pipelines to hold leading positions in AAV suspension processes, lentiviral GMP production, and plasmid CDMO. The Asia-Pacific region has become the fastest-growing and most rapidly expanding sector. China, with its leading global number of cell therapy clinical studies, policy support, and CXO industry chain advantages, is driving the rapid rise of autologous CAR-T CDMO, universal cell therapy, and viral vector outsourcing services, with domestic CDMOs quickly entering global competition. The industry as a whole is accelerating its evolution towards suspension process scale-up, gene editing integration, and automated closed-loop production.
LPI (LP Information)' newest research report, the “Cell and Gene Therapy CDMO Industry Forecast” looks at past sales and reviews total world Cell and Gene Therapy CDMO sales in 2025, providing a comprehensive analysis by region and market sector of projected Cell and Gene Therapy CDMO sales for 2026 through 2032. With Cell and Gene Therapy CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell and Gene Therapy CDMO industry.
This Insight Report provides a comprehensive analysis of the global Cell and Gene Therapy CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell and Gene Therapy CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell and Gene Therapy CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell and Gene Therapy CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell and Gene Therapy CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell and Gene Therapy CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
Cell and Gene Therapy CDMOs are organizations that provide professional, customized R&D and manufacturing outsourcing services for the research and commercialization of cell and gene therapy drugs. These services cover the entire chain of process development and manufacturing, from plasmids and viral vectors to cell drugs. Their core value lies in helping innovative cell and gene therapy (CGT) companies overcome industrialization bottlenecks caused by complex processes, high production costs, and stringent regulatory oversight, accelerating the drug development process from preclinical research to IND application and commercialization. Services include process development, analytical method development, GMP-level manufacturing, stability studies, and application document preparation, making them an indispensable key support force in modern CGT drug development.
The global Cell and Gene Therapy CDMO market is experiencing rapid growth driven by the surge in CGT drugs, pipeline advancements, and industrialization demands. North America and Europe, as mature markets, leverage their leading viral vector technologies, robust regulatory frameworks, and extensive CGT R&D pipelines to hold leading positions in AAV suspension processes, lentiviral GMP production, and plasmid CDMO. The Asia-Pacific region has become the fastest-growing and most rapidly expanding sector. China, with its leading global number of cell therapy clinical studies, policy support, and CXO industry chain advantages, is driving the rapid rise of autologous CAR-T CDMO, universal cell therapy, and viral vector outsourcing services, with domestic CDMOs quickly entering global competition. The industry as a whole is accelerating its evolution towards suspension process scale-up, gene editing integration, and automated closed-loop production.
LPI (LP Information)' newest research report, the “Cell and Gene Therapy CDMO Industry Forecast” looks at past sales and reviews total world Cell and Gene Therapy CDMO sales in 2025, providing a comprehensive analysis by region and market sector of projected Cell and Gene Therapy CDMO sales for 2026 through 2032. With Cell and Gene Therapy CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell and Gene Therapy CDMO industry.
This Insight Report provides a comprehensive analysis of the global Cell and Gene Therapy CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell and Gene Therapy CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell and Gene Therapy CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell and Gene Therapy CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell and Gene Therapy CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell and Gene Therapy CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Clinical Trial Material CDMOs
- Development and Manufacturing CDMOs
- Other
- R&D-Grade CDMO
- Clinical-Grade CDMO
- Commercial-Scale CDMO
- Plasmid DNA CDMO
- Viral Vector CDMO
- Cell Therapy CDMO
- mRNA Drug CDMO
- Gene Editing Drug CDMO
- Others
- Pharmaceutical Company
- Biotechnology Company
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lonza
- Charles River Laboratories
- Cytiva
- Catalent Biologics
- FUJIFILM Diosynth Biotechnologies
- Made Scientific
- RoslinCT
- Thermo Scientific
- Andelyn Biosciences
- WuXi AppTec
- AGC Biologics
- Pfizer CentreOne
- Almac Group
- PCI Pharma Services
- OmniaBio
- Minaris Advanced Therapies
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell and Gene Therapy CDMO Market Size (2021-2032)
2.1.2 Cell and Gene Therapy CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Cell and Gene Therapy CDMO by Country/Region (2021, 2025 & 2032)
2.2 Cell and Gene Therapy CDMO Segment by Type
2.2.1 Clinical Trial Material CDMOs
2.2.2 Development and Manufacturing CDMOs
2.2.3 Other
2.2.4 Cell and Gene Therapy CDMO Market Size by Type
2.2.4.1 Cell and Gene Therapy CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Cell and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
2.3 Cell and Gene Therapy CDMO Segment by Scale
2.3.1 R&D-Grade CDMO
2.3.2 Clinical-Grade CDMO
2.3.3 Commercial-Scale CDMO
2.3.4 Cell and Gene Therapy CDMO Market Size by Scale
2.3.4.1 Cell and Gene Therapy CDMO Market Size CAGR by Scale (2021 VS 2025 VS 2032)
2.3.4.2 Global Cell and Gene Therapy CDMO Market Size Market Share by Scale (2021-2026)
2.4 Cell and Gene Therapy CDMO Segment by Technology
2.4.1 Plasmid DNA CDMO
2.4.2 Viral Vector CDMO
2.4.3 Cell Therapy CDMO
2.4.4 mRNA Drug CDMO
2.4.5 Gene Editing Drug CDMO
2.4.6 Others
2.4.7 Cell and Gene Therapy CDMO Market Size by Technology
2.4.7.1 Cell and Gene Therapy CDMO Market Size CAGR by Technology (2021 VS 2025 VS 2032)
2.4.7.2 Global Cell and Gene Therapy CDMO Market Size Market Share by Technology (2021-2026)
2.5 Cell and Gene Therapy CDMO Segment by Application
2.5.1 Pharmaceutical Company
2.5.2 Biotechnology Company
2.5.3 Other
2.5.4 Cell and Gene Therapy CDMO Market Size by Application
2.5.4.1 Cell and Gene Therapy CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Cell and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
3 CELL AND GENE THERAPY CDMO MARKET SIZE BY PLAYER
3.1 Cell and Gene Therapy CDMO Market Size Market Share by Player
3.1.1 Global Cell and Gene Therapy CDMO Revenue by Player (2021-2026)
3.1.2 Global Cell and Gene Therapy CDMO Revenue Market Share by Player (2021-2026)
3.2 Global Cell and Gene Therapy CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL AND GENE THERAPY CDMO BY REGION
4.1 Cell and Gene Therapy CDMO Market Size by Region (2021-2026)
4.2 Global Cell and Gene Therapy CDMO Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cell and Gene Therapy CDMO Market Size Growth (2021-2026)
4.4 APAC Cell and Gene Therapy CDMO Market Size Growth (2021-2026)
4.5 Europe Cell and Gene Therapy CDMO Market Size Growth (2021-2026)
4.6 Middle East & Africa Cell and Gene Therapy CDMO Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Cell and Gene Therapy CDMO Market Size by Country (2021-2026)
5.2 Americas Cell and Gene Therapy CDMO Market Size by Type (2021-2026)
5.3 Americas Cell and Gene Therapy CDMO Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell and Gene Therapy CDMO Market Size by Region (2021-2026)
6.2 APAC Cell and Gene Therapy CDMO Market Size by Type (2021-2026)
6.3 APAC Cell and Gene Therapy CDMO Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell and Gene Therapy CDMO Market Size by Country (2021-2026)
7.2 Europe Cell and Gene Therapy CDMO Market Size by Type (2021-2026)
7.3 Europe Cell and Gene Therapy CDMO Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell and Gene Therapy CDMO by Region (2021-2026)
8.2 Middle East & Africa Cell and Gene Therapy CDMO Market Size by Type (2021-2026)
8.3 Middle East & Africa Cell and Gene Therapy CDMO Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL AND GENE THERAPY CDMO MARKET FORECAST
10.1 Global Cell and Gene Therapy CDMO Forecast by Region (2027-2032)
10.1.1 Global Cell and Gene Therapy CDMO Forecast by Region (2027-2032)
10.1.2 Americas Cell and Gene Therapy CDMO Forecast
10.1.3 APAC Cell and Gene Therapy CDMO Forecast
10.1.4 Europe Cell and Gene Therapy CDMO Forecast
10.1.5 Middle East & Africa Cell and Gene Therapy CDMO Forecast
10.2 Americas Cell and Gene Therapy CDMO Forecast by Country (2027-2032)
10.2.1 United States Market Cell and Gene Therapy CDMO Forecast
10.2.2 Canada Market Cell and Gene Therapy CDMO Forecast
10.2.3 Mexico Market Cell and Gene Therapy CDMO Forecast
10.2.4 Brazil Market Cell and Gene Therapy CDMO Forecast
10.3 APAC Cell and Gene Therapy CDMO Forecast by Region (2027-2032)
10.3.1 China Cell and Gene Therapy CDMO Market Forecast
10.3.2 Japan Market Cell and Gene Therapy CDMO Forecast
10.3.3 Korea Market Cell and Gene Therapy CDMO Forecast
10.3.4 Southeast Asia Market Cell and Gene Therapy CDMO Forecast
10.3.5 India Market Cell and Gene Therapy CDMO Forecast
10.3.6 Australia Market Cell and Gene Therapy CDMO Forecast
10.4 Europe Cell and Gene Therapy CDMO Forecast by Country (2027-2032)
10.4.1 Germany Market Cell and Gene Therapy CDMO Forecast
10.4.2 France Market Cell and Gene Therapy CDMO Forecast
10.4.3 UK Market Cell and Gene Therapy CDMO Forecast
10.4.4 Italy Market Cell and Gene Therapy CDMO Forecast
10.4.5 Russia Market Cell and Gene Therapy CDMO Forecast
10.5 Middle East & Africa Cell and Gene Therapy CDMO Forecast by Region (2027-2032)
10.5.1 Egypt Market Cell and Gene Therapy CDMO Forecast
10.5.2 South Africa Market Cell and Gene Therapy CDMO Forecast
10.5.3 Israel Market Cell and Gene Therapy CDMO Forecast
10.5.4 Turkey Market Cell and Gene Therapy CDMO Forecast
10.6 Global Cell and Gene Therapy CDMO Forecast by Type (2027-2032)
10.7 Global Cell and Gene Therapy CDMO Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Cell and Gene Therapy CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Cell and Gene Therapy CDMO Product Offered
11.1.3 Lonza Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Information
11.2.2 Charles River Laboratories Cell and Gene Therapy CDMO Product Offered
11.2.3 Charles River Laboratories Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Charles River Laboratories Main Business Overview
11.2.5 Charles River Laboratories Latest Developments
11.3 Cytiva
11.3.1 Cytiva Company Information
11.3.2 Cytiva Cell and Gene Therapy CDMO Product Offered
11.3.3 Cytiva Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Cytiva Main Business Overview
11.3.5 Cytiva Latest Developments
11.4 Catalent Biologics
11.4.1 Catalent Biologics Company Information
11.4.2 Catalent Biologics Cell and Gene Therapy CDMO Product Offered
11.4.3 Catalent Biologics Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Catalent Biologics Main Business Overview
11.4.5 Catalent Biologics Latest Developments
11.5 FUJIFILM Diosynth Biotechnologies
11.5.1 FUJIFILM Diosynth Biotechnologies Company Information
11.5.2 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Product Offered
11.5.3 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.5.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.6 Made Scientific
11.6.1 Made Scientific Company Information
11.6.2 Made Scientific Cell and Gene Therapy CDMO Product Offered
11.6.3 Made Scientific Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Made Scientific Main Business Overview
11.6.5 Made Scientific Latest Developments
11.7 RoslinCT
11.7.1 RoslinCT Company Information
11.7.2 RoslinCT Cell and Gene Therapy CDMO Product Offered
11.7.3 RoslinCT Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 RoslinCT Main Business Overview
11.7.5 RoslinCT Latest Developments
11.8 Thermo Scientific
11.8.1 Thermo Scientific Company Information
11.8.2 Thermo Scientific Cell and Gene Therapy CDMO Product Offered
11.8.3 Thermo Scientific Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Thermo Scientific Main Business Overview
11.8.5 Thermo Scientific Latest Developments
11.9 Andelyn Biosciences
11.9.1 Andelyn Biosciences Company Information
11.9.2 Andelyn Biosciences Cell and Gene Therapy CDMO Product Offered
11.9.3 Andelyn Biosciences Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Andelyn Biosciences Main Business Overview
11.9.5 Andelyn Biosciences Latest Developments
11.10 WuXi AppTec
11.10.1 WuXi AppTec Company Information
11.10.2 WuXi AppTec Cell and Gene Therapy CDMO Product Offered
11.10.3 WuXi AppTec Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 WuXi AppTec Main Business Overview
11.10.5 WuXi AppTec Latest Developments
11.11 AGC Biologics
11.11.1 AGC Biologics Company Information
11.11.2 AGC Biologics Cell and Gene Therapy CDMO Product Offered
11.11.3 AGC Biologics Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 AGC Biologics Main Business Overview
11.11.5 AGC Biologics Latest Developments
11.12 Pfizer CentreOne
11.12.1 Pfizer CentreOne Company Information
11.12.2 Pfizer CentreOne Cell and Gene Therapy CDMO Product Offered
11.12.3 Pfizer CentreOne Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Pfizer CentreOne Main Business Overview
11.12.5 Pfizer CentreOne Latest Developments
11.13 Almac Group
11.13.1 Almac Group Company Information
11.13.2 Almac Group Cell and Gene Therapy CDMO Product Offered
11.13.3 Almac Group Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Almac Group Main Business Overview
11.13.5 Almac Group Latest Developments
11.14 PCI Pharma Services
11.14.1 PCI Pharma Services Company Information
11.14.2 PCI Pharma Services Cell and Gene Therapy CDMO Product Offered
11.14.3 PCI Pharma Services Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 PCI Pharma Services Main Business Overview
11.14.5 PCI Pharma Services Latest Developments
11.15 OmniaBio
11.15.1 OmniaBio Company Information
11.15.2 OmniaBio Cell and Gene Therapy CDMO Product Offered
11.15.3 OmniaBio Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 OmniaBio Main Business Overview
11.15.5 OmniaBio Latest Developments
11.16 Minaris Advanced Therapies
11.16.1 Minaris Advanced Therapies Company Information
11.16.2 Minaris Advanced Therapies Cell and Gene Therapy CDMO Product Offered
11.16.3 Minaris Advanced Therapies Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Minaris Advanced Therapies Main Business Overview
11.16.5 Minaris Advanced Therapies Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell and Gene Therapy CDMO Market Size (2021-2032)
2.1.2 Cell and Gene Therapy CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Cell and Gene Therapy CDMO by Country/Region (2021, 2025 & 2032)
2.2 Cell and Gene Therapy CDMO Segment by Type
2.2.1 Clinical Trial Material CDMOs
2.2.2 Development and Manufacturing CDMOs
2.2.3 Other
2.2.4 Cell and Gene Therapy CDMO Market Size by Type
2.2.4.1 Cell and Gene Therapy CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Cell and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
2.3 Cell and Gene Therapy CDMO Segment by Scale
2.3.1 R&D-Grade CDMO
2.3.2 Clinical-Grade CDMO
2.3.3 Commercial-Scale CDMO
2.3.4 Cell and Gene Therapy CDMO Market Size by Scale
2.3.4.1 Cell and Gene Therapy CDMO Market Size CAGR by Scale (2021 VS 2025 VS 2032)
2.3.4.2 Global Cell and Gene Therapy CDMO Market Size Market Share by Scale (2021-2026)
2.4 Cell and Gene Therapy CDMO Segment by Technology
2.4.1 Plasmid DNA CDMO
2.4.2 Viral Vector CDMO
2.4.3 Cell Therapy CDMO
2.4.4 mRNA Drug CDMO
2.4.5 Gene Editing Drug CDMO
2.4.6 Others
2.4.7 Cell and Gene Therapy CDMO Market Size by Technology
2.4.7.1 Cell and Gene Therapy CDMO Market Size CAGR by Technology (2021 VS 2025 VS 2032)
2.4.7.2 Global Cell and Gene Therapy CDMO Market Size Market Share by Technology (2021-2026)
2.5 Cell and Gene Therapy CDMO Segment by Application
2.5.1 Pharmaceutical Company
2.5.2 Biotechnology Company
2.5.3 Other
2.5.4 Cell and Gene Therapy CDMO Market Size by Application
2.5.4.1 Cell and Gene Therapy CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Cell and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
3 CELL AND GENE THERAPY CDMO MARKET SIZE BY PLAYER
3.1 Cell and Gene Therapy CDMO Market Size Market Share by Player
3.1.1 Global Cell and Gene Therapy CDMO Revenue by Player (2021-2026)
3.1.2 Global Cell and Gene Therapy CDMO Revenue Market Share by Player (2021-2026)
3.2 Global Cell and Gene Therapy CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL AND GENE THERAPY CDMO BY REGION
4.1 Cell and Gene Therapy CDMO Market Size by Region (2021-2026)
4.2 Global Cell and Gene Therapy CDMO Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cell and Gene Therapy CDMO Market Size Growth (2021-2026)
4.4 APAC Cell and Gene Therapy CDMO Market Size Growth (2021-2026)
4.5 Europe Cell and Gene Therapy CDMO Market Size Growth (2021-2026)
4.6 Middle East & Africa Cell and Gene Therapy CDMO Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Cell and Gene Therapy CDMO Market Size by Country (2021-2026)
5.2 Americas Cell and Gene Therapy CDMO Market Size by Type (2021-2026)
5.3 Americas Cell and Gene Therapy CDMO Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell and Gene Therapy CDMO Market Size by Region (2021-2026)
6.2 APAC Cell and Gene Therapy CDMO Market Size by Type (2021-2026)
6.3 APAC Cell and Gene Therapy CDMO Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell and Gene Therapy CDMO Market Size by Country (2021-2026)
7.2 Europe Cell and Gene Therapy CDMO Market Size by Type (2021-2026)
7.3 Europe Cell and Gene Therapy CDMO Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell and Gene Therapy CDMO by Region (2021-2026)
8.2 Middle East & Africa Cell and Gene Therapy CDMO Market Size by Type (2021-2026)
8.3 Middle East & Africa Cell and Gene Therapy CDMO Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL AND GENE THERAPY CDMO MARKET FORECAST
10.1 Global Cell and Gene Therapy CDMO Forecast by Region (2027-2032)
10.1.1 Global Cell and Gene Therapy CDMO Forecast by Region (2027-2032)
10.1.2 Americas Cell and Gene Therapy CDMO Forecast
10.1.3 APAC Cell and Gene Therapy CDMO Forecast
10.1.4 Europe Cell and Gene Therapy CDMO Forecast
10.1.5 Middle East & Africa Cell and Gene Therapy CDMO Forecast
10.2 Americas Cell and Gene Therapy CDMO Forecast by Country (2027-2032)
10.2.1 United States Market Cell and Gene Therapy CDMO Forecast
10.2.2 Canada Market Cell and Gene Therapy CDMO Forecast
10.2.3 Mexico Market Cell and Gene Therapy CDMO Forecast
10.2.4 Brazil Market Cell and Gene Therapy CDMO Forecast
10.3 APAC Cell and Gene Therapy CDMO Forecast by Region (2027-2032)
10.3.1 China Cell and Gene Therapy CDMO Market Forecast
10.3.2 Japan Market Cell and Gene Therapy CDMO Forecast
10.3.3 Korea Market Cell and Gene Therapy CDMO Forecast
10.3.4 Southeast Asia Market Cell and Gene Therapy CDMO Forecast
10.3.5 India Market Cell and Gene Therapy CDMO Forecast
10.3.6 Australia Market Cell and Gene Therapy CDMO Forecast
10.4 Europe Cell and Gene Therapy CDMO Forecast by Country (2027-2032)
10.4.1 Germany Market Cell and Gene Therapy CDMO Forecast
10.4.2 France Market Cell and Gene Therapy CDMO Forecast
10.4.3 UK Market Cell and Gene Therapy CDMO Forecast
10.4.4 Italy Market Cell and Gene Therapy CDMO Forecast
10.4.5 Russia Market Cell and Gene Therapy CDMO Forecast
10.5 Middle East & Africa Cell and Gene Therapy CDMO Forecast by Region (2027-2032)
10.5.1 Egypt Market Cell and Gene Therapy CDMO Forecast
10.5.2 South Africa Market Cell and Gene Therapy CDMO Forecast
10.5.3 Israel Market Cell and Gene Therapy CDMO Forecast
10.5.4 Turkey Market Cell and Gene Therapy CDMO Forecast
10.6 Global Cell and Gene Therapy CDMO Forecast by Type (2027-2032)
10.7 Global Cell and Gene Therapy CDMO Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Cell and Gene Therapy CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Cell and Gene Therapy CDMO Product Offered
11.1.3 Lonza Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Information
11.2.2 Charles River Laboratories Cell and Gene Therapy CDMO Product Offered
11.2.3 Charles River Laboratories Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Charles River Laboratories Main Business Overview
11.2.5 Charles River Laboratories Latest Developments
11.3 Cytiva
11.3.1 Cytiva Company Information
11.3.2 Cytiva Cell and Gene Therapy CDMO Product Offered
11.3.3 Cytiva Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Cytiva Main Business Overview
11.3.5 Cytiva Latest Developments
11.4 Catalent Biologics
11.4.1 Catalent Biologics Company Information
11.4.2 Catalent Biologics Cell and Gene Therapy CDMO Product Offered
11.4.3 Catalent Biologics Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Catalent Biologics Main Business Overview
11.4.5 Catalent Biologics Latest Developments
11.5 FUJIFILM Diosynth Biotechnologies
11.5.1 FUJIFILM Diosynth Biotechnologies Company Information
11.5.2 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Product Offered
11.5.3 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.5.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.6 Made Scientific
11.6.1 Made Scientific Company Information
11.6.2 Made Scientific Cell and Gene Therapy CDMO Product Offered
11.6.3 Made Scientific Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Made Scientific Main Business Overview
11.6.5 Made Scientific Latest Developments
11.7 RoslinCT
11.7.1 RoslinCT Company Information
11.7.2 RoslinCT Cell and Gene Therapy CDMO Product Offered
11.7.3 RoslinCT Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 RoslinCT Main Business Overview
11.7.5 RoslinCT Latest Developments
11.8 Thermo Scientific
11.8.1 Thermo Scientific Company Information
11.8.2 Thermo Scientific Cell and Gene Therapy CDMO Product Offered
11.8.3 Thermo Scientific Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Thermo Scientific Main Business Overview
11.8.5 Thermo Scientific Latest Developments
11.9 Andelyn Biosciences
11.9.1 Andelyn Biosciences Company Information
11.9.2 Andelyn Biosciences Cell and Gene Therapy CDMO Product Offered
11.9.3 Andelyn Biosciences Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Andelyn Biosciences Main Business Overview
11.9.5 Andelyn Biosciences Latest Developments
11.10 WuXi AppTec
11.10.1 WuXi AppTec Company Information
11.10.2 WuXi AppTec Cell and Gene Therapy CDMO Product Offered
11.10.3 WuXi AppTec Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 WuXi AppTec Main Business Overview
11.10.5 WuXi AppTec Latest Developments
11.11 AGC Biologics
11.11.1 AGC Biologics Company Information
11.11.2 AGC Biologics Cell and Gene Therapy CDMO Product Offered
11.11.3 AGC Biologics Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 AGC Biologics Main Business Overview
11.11.5 AGC Biologics Latest Developments
11.12 Pfizer CentreOne
11.12.1 Pfizer CentreOne Company Information
11.12.2 Pfizer CentreOne Cell and Gene Therapy CDMO Product Offered
11.12.3 Pfizer CentreOne Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Pfizer CentreOne Main Business Overview
11.12.5 Pfizer CentreOne Latest Developments
11.13 Almac Group
11.13.1 Almac Group Company Information
11.13.2 Almac Group Cell and Gene Therapy CDMO Product Offered
11.13.3 Almac Group Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Almac Group Main Business Overview
11.13.5 Almac Group Latest Developments
11.14 PCI Pharma Services
11.14.1 PCI Pharma Services Company Information
11.14.2 PCI Pharma Services Cell and Gene Therapy CDMO Product Offered
11.14.3 PCI Pharma Services Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 PCI Pharma Services Main Business Overview
11.14.5 PCI Pharma Services Latest Developments
11.15 OmniaBio
11.15.1 OmniaBio Company Information
11.15.2 OmniaBio Cell and Gene Therapy CDMO Product Offered
11.15.3 OmniaBio Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 OmniaBio Main Business Overview
11.15.5 OmniaBio Latest Developments
11.16 Minaris Advanced Therapies
11.16.1 Minaris Advanced Therapies Company Information
11.16.2 Minaris Advanced Therapies Cell and Gene Therapy CDMO Product Offered
11.16.3 Minaris Advanced Therapies Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Minaris Advanced Therapies Main Business Overview
11.16.5 Minaris Advanced Therapies Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cell and Gene Therapy CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cell and Gene Therapy CDMO Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Clinical Trial Material CDMOs
Table 4. Major Players of Development and Manufacturing CDMOs
Table 5. Major Players of Other
Table 6. Cell and Gene Therapy CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Cell and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Cell and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Table 9. Major Players of R&D-Grade CDMO
Table 10. Major Players of Clinical-Grade CDMO
Table 11. Major Players of Commercial-Scale CDMO
Table 12. Cell and Gene Therapy CDMO Market Size CAGR by Scale (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Cell and Gene Therapy CDMO Market Size by Scale (2021-2026) & ($ millions)
Table 14. Global Cell and Gene Therapy CDMO Market Size Market Share by Scale (2021-2026)
Table 15. Major Players of Plasmid DNA CDMO
Table 16. Major Players of Viral Vector CDMO
Table 17. Major Players of Cell Therapy CDMO
Table 18. Major Players of mRNA Drug CDMO
Table 19. Major Players of Gene Editing Drug CDMO
Table 20. Major Players of Others
Table 21. Cell and Gene Therapy CDMO Market Size CAGR by Technology (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Cell and Gene Therapy CDMO Market Size by Technology (2021-2026) & ($ millions)
Table 23. Global Cell and Gene Therapy CDMO Market Size Market Share by Technology (2021-2026)
Table 24. Cell and Gene Therapy CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 25. Global Cell and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 26. Global Cell and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Table 27. Global Cell and Gene Therapy CDMO Revenue by Player (2021-2026) & ($ millions)
Table 28. Global Cell and Gene Therapy CDMO Revenue Market Share by Player (2021-2026)
Table 29. Cell and Gene Therapy CDMO Key Players Head office and Products Offered
Table 30. Cell and Gene Therapy CDMO Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 31. New Products and Potential Entrants
Table 32. Mergers & Acquisitions, Expansion
Table 33. Global Cell and Gene Therapy CDMO Market Size by Region (2021-2026) & ($ millions)
Table 34. Global Cell and Gene Therapy CDMO Market Size Market Share by Region (2021-2026)
Table 35. Global Cell and Gene Therapy CDMO Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Cell and Gene Therapy CDMO Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Cell and Gene Therapy CDMO Market Size by Country (2021-2026) & ($ millions)
Table 38. Americas Cell and Gene Therapy CDMO Market Size Market Share by Country (2021-2026)
Table 39. Americas Cell and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 40. Americas Cell and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Table 41. Americas Cell and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 42. Americas Cell and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Table 43. APAC Cell and Gene Therapy CDMO Market Size by Region (2021-2026) & ($ millions)
Table 44. APAC Cell and Gene Therapy CDMO Market Size Market Share by Region (2021-2026)
Table 45. APAC Cell and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 46. APAC Cell and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 47. Europe Cell and Gene Therapy CDMO Market Size by Country (2021-2026) & ($ millions)
Table 48. Europe Cell and Gene Therapy CDMO Market Size Market Share by Country (2021-2026)
Table 49. Europe Cell and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 50. Europe Cell and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 51. Middle East & Africa Cell and Gene Therapy CDMO Market Size by Region (2021-2026) & ($ millions)
Table 52. Middle East & Africa Cell and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 53. Middle East & Africa Cell and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 54. Key Market Drivers & Growth Opportunities of Cell and Gene Therapy CDMO
Table 55. Key Market Challenges & Risks of Cell and Gene Therapy CDMO
Table 56. Key Industry Trends of Cell and Gene Therapy CDMO
Table 57. Global Cell and Gene Therapy CDMO Market Size Forecast by Region (2027-2032) & ($ millions)
Table 58. Global Cell and Gene Therapy CDMO Market Size Market Share Forecast by Region (2027-2032)
Table 59. Global Cell and Gene Therapy CDMO Market Size Forecast by Type (2027-2032) & ($ millions)
Table 60. Global Cell and Gene Therapy CDMO Market Size Forecast by Application (2027-2032) & ($ millions)
Table 61. Lonza Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 62. Lonza Cell and Gene Therapy CDMO Product Offered
Table 63. Lonza Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Lonza Main Business
Table 65. Lonza Latest Developments
Table 66. Charles River Laboratories Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 67. Charles River Laboratories Cell and Gene Therapy CDMO Product Offered
Table 68. Charles River Laboratories Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Charles River Laboratories Main Business
Table 70. Charles River Laboratories Latest Developments
Table 71. Cytiva Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 72. Cytiva Cell and Gene Therapy CDMO Product Offered
Table 73. Cytiva Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Cytiva Main Business
Table 75. Cytiva Latest Developments
Table 76. Catalent Biologics Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 77. Catalent Biologics Cell and Gene Therapy CDMO Product Offered
Table 78. Catalent Biologics Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Catalent Biologics Main Business
Table 80. Catalent Biologics Latest Developments
Table 81. FUJIFILM Diosynth Biotechnologies Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 82. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Product Offered
Table 83. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. FUJIFILM Diosynth Biotechnologies Main Business
Table 85. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 86. Made Scientific Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 87. Made Scientific Cell and Gene Therapy CDMO Product Offered
Table 88. Made Scientific Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Made Scientific Main Business
Table 90. Made Scientific Latest Developments
Table 91. RoslinCT Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 92. RoslinCT Cell and Gene Therapy CDMO Product Offered
Table 93. RoslinCT Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. RoslinCT Main Business
Table 95. RoslinCT Latest Developments
Table 96. Thermo Scientific Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 97. Thermo Scientific Cell and Gene Therapy CDMO Product Offered
Table 98. Thermo Scientific Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Thermo Scientific Main Business
Table 100. Thermo Scientific Latest Developments
Table 101. Andelyn Biosciences Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 102. Andelyn Biosciences Cell and Gene Therapy CDMO Product Offered
Table 103. Andelyn Biosciences Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Andelyn Biosciences Main Business
Table 105. Andelyn Biosciences Latest Developments
Table 106. WuXi AppTec Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 107. WuXi AppTec Cell and Gene Therapy CDMO Product Offered
Table 108. WuXi AppTec Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. WuXi AppTec Main Business
Table 110. WuXi AppTec Latest Developments
Table 111. AGC Biologics Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 112. AGC Biologics Cell and Gene Therapy CDMO Product Offered
Table 113. AGC Biologics Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. AGC Biologics Main Business
Table 115. AGC Biologics Latest Developments
Table 116. Pfizer CentreOne Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 117. Pfizer CentreOne Cell and Gene Therapy CDMO Product Offered
Table 118. Pfizer CentreOne Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Pfizer CentreOne Main Business
Table 120. Pfizer CentreOne Latest Developments
Table 121. Almac Group Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 122. Almac Group Cell and Gene Therapy CDMO Product Offered
Table 123. Almac Group Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Almac Group Main Business
Table 125. Almac Group Latest Developments
Table 126. PCI Pharma Services Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 127. PCI Pharma Services Cell and Gene Therapy CDMO Product Offered
Table 128. PCI Pharma Services Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. PCI Pharma Services Main Business
Table 130. PCI Pharma Services Latest Developments
Table 131. OmniaBio Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 132. OmniaBio Cell and Gene Therapy CDMO Product Offered
Table 133. OmniaBio Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. OmniaBio Main Business
Table 135. OmniaBio Latest Developments
Table 136. Minaris Advanced Therapies Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 137. Minaris Advanced Therapies Cell and Gene Therapy CDMO Product Offered
Table 138. Minaris Advanced Therapies Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Minaris Advanced Therapies Main Business
Table 140. Minaris Advanced Therapies Latest Developments
Table 1. Cell and Gene Therapy CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cell and Gene Therapy CDMO Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Clinical Trial Material CDMOs
Table 4. Major Players of Development and Manufacturing CDMOs
Table 5. Major Players of Other
Table 6. Cell and Gene Therapy CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Cell and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Cell and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Table 9. Major Players of R&D-Grade CDMO
Table 10. Major Players of Clinical-Grade CDMO
Table 11. Major Players of Commercial-Scale CDMO
Table 12. Cell and Gene Therapy CDMO Market Size CAGR by Scale (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Cell and Gene Therapy CDMO Market Size by Scale (2021-2026) & ($ millions)
Table 14. Global Cell and Gene Therapy CDMO Market Size Market Share by Scale (2021-2026)
Table 15. Major Players of Plasmid DNA CDMO
Table 16. Major Players of Viral Vector CDMO
Table 17. Major Players of Cell Therapy CDMO
Table 18. Major Players of mRNA Drug CDMO
Table 19. Major Players of Gene Editing Drug CDMO
Table 20. Major Players of Others
Table 21. Cell and Gene Therapy CDMO Market Size CAGR by Technology (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Cell and Gene Therapy CDMO Market Size by Technology (2021-2026) & ($ millions)
Table 23. Global Cell and Gene Therapy CDMO Market Size Market Share by Technology (2021-2026)
Table 24. Cell and Gene Therapy CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 25. Global Cell and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 26. Global Cell and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Table 27. Global Cell and Gene Therapy CDMO Revenue by Player (2021-2026) & ($ millions)
Table 28. Global Cell and Gene Therapy CDMO Revenue Market Share by Player (2021-2026)
Table 29. Cell and Gene Therapy CDMO Key Players Head office and Products Offered
Table 30. Cell and Gene Therapy CDMO Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 31. New Products and Potential Entrants
Table 32. Mergers & Acquisitions, Expansion
Table 33. Global Cell and Gene Therapy CDMO Market Size by Region (2021-2026) & ($ millions)
Table 34. Global Cell and Gene Therapy CDMO Market Size Market Share by Region (2021-2026)
Table 35. Global Cell and Gene Therapy CDMO Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Cell and Gene Therapy CDMO Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Cell and Gene Therapy CDMO Market Size by Country (2021-2026) & ($ millions)
Table 38. Americas Cell and Gene Therapy CDMO Market Size Market Share by Country (2021-2026)
Table 39. Americas Cell and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 40. Americas Cell and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Table 41. Americas Cell and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 42. Americas Cell and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Table 43. APAC Cell and Gene Therapy CDMO Market Size by Region (2021-2026) & ($ millions)
Table 44. APAC Cell and Gene Therapy CDMO Market Size Market Share by Region (2021-2026)
Table 45. APAC Cell and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 46. APAC Cell and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 47. Europe Cell and Gene Therapy CDMO Market Size by Country (2021-2026) & ($ millions)
Table 48. Europe Cell and Gene Therapy CDMO Market Size Market Share by Country (2021-2026)
Table 49. Europe Cell and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 50. Europe Cell and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 51. Middle East & Africa Cell and Gene Therapy CDMO Market Size by Region (2021-2026) & ($ millions)
Table 52. Middle East & Africa Cell and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 53. Middle East & Africa Cell and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 54. Key Market Drivers & Growth Opportunities of Cell and Gene Therapy CDMO
Table 55. Key Market Challenges & Risks of Cell and Gene Therapy CDMO
Table 56. Key Industry Trends of Cell and Gene Therapy CDMO
Table 57. Global Cell and Gene Therapy CDMO Market Size Forecast by Region (2027-2032) & ($ millions)
Table 58. Global Cell and Gene Therapy CDMO Market Size Market Share Forecast by Region (2027-2032)
Table 59. Global Cell and Gene Therapy CDMO Market Size Forecast by Type (2027-2032) & ($ millions)
Table 60. Global Cell and Gene Therapy CDMO Market Size Forecast by Application (2027-2032) & ($ millions)
Table 61. Lonza Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 62. Lonza Cell and Gene Therapy CDMO Product Offered
Table 63. Lonza Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Lonza Main Business
Table 65. Lonza Latest Developments
Table 66. Charles River Laboratories Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 67. Charles River Laboratories Cell and Gene Therapy CDMO Product Offered
Table 68. Charles River Laboratories Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Charles River Laboratories Main Business
Table 70. Charles River Laboratories Latest Developments
Table 71. Cytiva Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 72. Cytiva Cell and Gene Therapy CDMO Product Offered
Table 73. Cytiva Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Cytiva Main Business
Table 75. Cytiva Latest Developments
Table 76. Catalent Biologics Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 77. Catalent Biologics Cell and Gene Therapy CDMO Product Offered
Table 78. Catalent Biologics Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Catalent Biologics Main Business
Table 80. Catalent Biologics Latest Developments
Table 81. FUJIFILM Diosynth Biotechnologies Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 82. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Product Offered
Table 83. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. FUJIFILM Diosynth Biotechnologies Main Business
Table 85. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 86. Made Scientific Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 87. Made Scientific Cell and Gene Therapy CDMO Product Offered
Table 88. Made Scientific Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Made Scientific Main Business
Table 90. Made Scientific Latest Developments
Table 91. RoslinCT Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 92. RoslinCT Cell and Gene Therapy CDMO Product Offered
Table 93. RoslinCT Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. RoslinCT Main Business
Table 95. RoslinCT Latest Developments
Table 96. Thermo Scientific Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 97. Thermo Scientific Cell and Gene Therapy CDMO Product Offered
Table 98. Thermo Scientific Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Thermo Scientific Main Business
Table 100. Thermo Scientific Latest Developments
Table 101. Andelyn Biosciences Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 102. Andelyn Biosciences Cell and Gene Therapy CDMO Product Offered
Table 103. Andelyn Biosciences Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Andelyn Biosciences Main Business
Table 105. Andelyn Biosciences Latest Developments
Table 106. WuXi AppTec Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 107. WuXi AppTec Cell and Gene Therapy CDMO Product Offered
Table 108. WuXi AppTec Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. WuXi AppTec Main Business
Table 110. WuXi AppTec Latest Developments
Table 111. AGC Biologics Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 112. AGC Biologics Cell and Gene Therapy CDMO Product Offered
Table 113. AGC Biologics Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. AGC Biologics Main Business
Table 115. AGC Biologics Latest Developments
Table 116. Pfizer CentreOne Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 117. Pfizer CentreOne Cell and Gene Therapy CDMO Product Offered
Table 118. Pfizer CentreOne Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Pfizer CentreOne Main Business
Table 120. Pfizer CentreOne Latest Developments
Table 121. Almac Group Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 122. Almac Group Cell and Gene Therapy CDMO Product Offered
Table 123. Almac Group Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Almac Group Main Business
Table 125. Almac Group Latest Developments
Table 126. PCI Pharma Services Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 127. PCI Pharma Services Cell and Gene Therapy CDMO Product Offered
Table 128. PCI Pharma Services Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. PCI Pharma Services Main Business
Table 130. PCI Pharma Services Latest Developments
Table 131. OmniaBio Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 132. OmniaBio Cell and Gene Therapy CDMO Product Offered
Table 133. OmniaBio Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. OmniaBio Main Business
Table 135. OmniaBio Latest Developments
Table 136. Minaris Advanced Therapies Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 137. Minaris Advanced Therapies Cell and Gene Therapy CDMO Product Offered
Table 138. Minaris Advanced Therapies Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Minaris Advanced Therapies Main Business
Table 140. Minaris Advanced Therapies Latest Developments
LIST OF FIGURES
Figure 1. Cell and Gene Therapy CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell and Gene Therapy CDMO Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cell and Gene Therapy CDMO Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cell and Gene Therapy CDMO Sales Market Share by Country/Region (2025)
Figure 8. Cell and Gene Therapy CDMO Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cell and Gene Therapy CDMO Market Size Market Share by Type in 2025
Figure 10. Global Cell and Gene Therapy CDMO Market Size Market Share by Scale in 2025
Figure 11. Global Cell and Gene Therapy CDMO Market Size Market Share by Technology in 2025
Figure 12. Cell and Gene Therapy CDMO in Pharmaceutical Company
Figure 13. Global Cell and Gene Therapy CDMO Market: Pharmaceutical Company (2021-2026) & ($ millions)
Figure 14. Cell and Gene Therapy CDMO in Biotechnology Company
Figure 15. Global Cell and Gene Therapy CDMO Market: Biotechnology Company (2021-2026) & ($ millions)
Figure 16. Cell and Gene Therapy CDMO in Other
Figure 17. Global Cell and Gene Therapy CDMO Market: Other (2021-2026) & ($ millions)
Figure 18. Global Cell and Gene Therapy CDMO Market Size Market Share by Application in 2025
Figure 19. Global Cell and Gene Therapy CDMO Revenue Market Share by Player in 2025
Figure 20. Global Cell and Gene Therapy CDMO Market Size Market Share by Region (2021-2026)
Figure 21. Americas Cell and Gene Therapy CDMO Market Size 2021-2026 ($ millions)
Figure 22. APAC Cell and Gene Therapy CDMO Market Size 2021-2026 ($ millions)
Figure 23. Europe Cell and Gene Therapy CDMO Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Cell and Gene Therapy CDMO Market Size 2021-2026 ($ millions)
Figure 25. Americas Cell and Gene Therapy CDMO Value Market Share by Country in 2025
Figure 26. United States Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Cell and Gene Therapy CDMO Market Size Market Share by Region in 2025
Figure 31. APAC Cell and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Figure 32. APAC Cell and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Figure 33. China Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 37. India Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Cell and Gene Therapy CDMO Market Size Market Share by Country in 2025
Figure 40. Europe Cell and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Figure 41. Europe Cell and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Figure 42. Germany Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 43. France Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Cell and Gene Therapy CDMO Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Cell and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Cell and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 56. APAC Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 57. Europe Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 59. United States Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 60. Canada Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 61. Mexico Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 62. Brazil Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 63. China Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 64. Japan Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 65. Korea Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 67. India Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 68. Australia Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 69. Germany Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 70. France Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 71. UK Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 72. Italy Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 73. Russia Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 74. Egypt Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 75. South Africa Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 76. Israel Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 77. Turkey Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 78. Global Cell and Gene Therapy CDMO Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Cell and Gene Therapy CDMO Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 1. Cell and Gene Therapy CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell and Gene Therapy CDMO Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cell and Gene Therapy CDMO Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cell and Gene Therapy CDMO Sales Market Share by Country/Region (2025)
Figure 8. Cell and Gene Therapy CDMO Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cell and Gene Therapy CDMO Market Size Market Share by Type in 2025
Figure 10. Global Cell and Gene Therapy CDMO Market Size Market Share by Scale in 2025
Figure 11. Global Cell and Gene Therapy CDMO Market Size Market Share by Technology in 2025
Figure 12. Cell and Gene Therapy CDMO in Pharmaceutical Company
Figure 13. Global Cell and Gene Therapy CDMO Market: Pharmaceutical Company (2021-2026) & ($ millions)
Figure 14. Cell and Gene Therapy CDMO in Biotechnology Company
Figure 15. Global Cell and Gene Therapy CDMO Market: Biotechnology Company (2021-2026) & ($ millions)
Figure 16. Cell and Gene Therapy CDMO in Other
Figure 17. Global Cell and Gene Therapy CDMO Market: Other (2021-2026) & ($ millions)
Figure 18. Global Cell and Gene Therapy CDMO Market Size Market Share by Application in 2025
Figure 19. Global Cell and Gene Therapy CDMO Revenue Market Share by Player in 2025
Figure 20. Global Cell and Gene Therapy CDMO Market Size Market Share by Region (2021-2026)
Figure 21. Americas Cell and Gene Therapy CDMO Market Size 2021-2026 ($ millions)
Figure 22. APAC Cell and Gene Therapy CDMO Market Size 2021-2026 ($ millions)
Figure 23. Europe Cell and Gene Therapy CDMO Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Cell and Gene Therapy CDMO Market Size 2021-2026 ($ millions)
Figure 25. Americas Cell and Gene Therapy CDMO Value Market Share by Country in 2025
Figure 26. United States Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Cell and Gene Therapy CDMO Market Size Market Share by Region in 2025
Figure 31. APAC Cell and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Figure 32. APAC Cell and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Figure 33. China Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 37. India Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Cell and Gene Therapy CDMO Market Size Market Share by Country in 2025
Figure 40. Europe Cell and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Figure 41. Europe Cell and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Figure 42. Germany Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 43. France Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Cell and Gene Therapy CDMO Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Cell and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Cell and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Cell and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 56. APAC Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 57. Europe Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 59. United States Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 60. Canada Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 61. Mexico Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 62. Brazil Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 63. China Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 64. Japan Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 65. Korea Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 67. India Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 68. Australia Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 69. Germany Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 70. France Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 71. UK Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 72. Italy Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 73. Russia Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 74. Egypt Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 75. South Africa Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 76. Israel Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 77. Turkey Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 78. Global Cell and Gene Therapy CDMO Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Cell and Gene Therapy CDMO Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Cell and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
